Skip to Main Content

Paper Details

Mycophenolate mofetil reduces STAT3 phosphorylation in systemic lupus erythematosus patients.
JCI Insight
30
2019
CD4, CD4+, CD4+ Th17-type, CXCL12, CXCL9, IL-6, MIG, MMF, Mycophenolate mofetil, PBMCs, PDGF-BB, SDF-1, SLE, STAT3, Systemic lupus erythematosus, T cells, Treg-type cells, VEGF-A, autoimmune disease, cell subsets, lupus nephritis, mycophenolate mofetil, mycophenolic acid, nephritis, p-STAT3, patients, plasmablasts, systemic lupus erythematosus, transitional B cells
Author NameAffiliation
Joel M GuthridgeDepartment of Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation
Joel M GuthridgeUniversity of Oklahoma Health Sciences Center
Holden T MaeckerInstitute for Immunity
Paul J UtzStanford University School of Medicine
  • 1 - 4

Datasets

Release 1.2